Mutations of the interfacial residues in DET1 to glycine or alanine, including R488A/H485G, R488A/H485G/R306G/S312G or R488A/H485G/E380A/T382A reduced the interaction between DET1 and COP1
Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, Harger A, Schipke J, Zimmermann A, Schmidt A, Tong M, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, Magnes C, Trausinger G, Narath S, Meinitzer A, Hu Z, Kirsch A, Eller K, Carmona-Gutierrez D, Bttner S, Pietrocola F, Knittelfelder O, Schrepfer E, Rockenfeller P, Simonini C, Rahn A, Horsch M, Moreth K, Beckers J, Fuchs H, Gailus-Durner V, Neff F, Janik D, Rathkolb B, Rozman J, de Angelis MH, Moustafa T, Haemmerle G, Mayr M, Willeit P, von Frieling-Salewsky M, Pieske B, Scorrano L, Pieber T, Pechlaner R, Willeit J, Sigrist SJ, Linke WA, Mhlfeld C, Sadoshima J, Dengjel J, Kiechl S, Kroemer G, Sedej S, Madeo F
Cellular Aging and Telomere Research Telomere shortening at chromosome ends contributes to cellular aging
Why researchers combine cagrilintide with retatrutide The rationale behind this combination is not complicated, but it is deeply rooted in receptor pharmacology
Its systemic distribution and versatility are why it is often studied as a complement to more locally acting compounds